#1 Clinical Trials Search in Europe

Lacosamide

This article examines the use of lacosamide, an antiepileptic drug, in various clinical trials. Lacosamide has been studied as an adjunctive therapy and potential monotherapy for partial-onset seizures in both adults and children with epilepsy. The trials have investigated the drug’s safety, tolerability, efficacy, and optimal dosing across different patient populations.

Table of Contents

What is Lacosamide?

Lacosamide, also known by its brand name Vimpat, is an anti-epileptic medication used to treat seizures[1]. It belongs to a class of drugs called anticonvulsants, which work by reducing abnormal electrical activity in the brain[2]. Lacosamide is available in various forms, including oral tablets, oral solution (syrup), and as an intravenous (IV) injection[1][2].

Uses of Lacosamide

Lacosamide is primarily used to treat the following conditions:

  • Partial-onset seizures: These are seizures that start in one specific area of the brain. Lacosamide is used as an add-on therapy (meaning it’s used alongside other anti-epileptic drugs) in adults and children as young as 1 month old with partial-onset seizures[1][2].
  • Generalized seizures: These are seizures that involve the entire brain. Lacosamide has been studied for use in children with epilepsy syndromes associated with generalized seizures[1].
  • Migraine prevention: While not its primary use, Lacosamide has been studied for its potential in preventing migraines[3].
  • Acute sciatica: Some research has explored the use of Lacosamide in combination with other drugs for treating severe pain associated with acute sciatica (pain that radiates along the sciatic nerve)[4].

How Lacosamide Works

Lacosamide works by stabilizing the electrical activity in the brain. It does this by targeting specific sodium channels in brain cells. These channels are responsible for the transmission of electrical signals between neurons (brain cells). By modulating these channels, Lacosamide helps to reduce the abnormal electrical activity that can lead to seizures[2].

Administration and Dosage

Lacosamide can be administered in several ways:

  • Oral tablets: Available in various strengths, typically taken twice daily[1].
  • Oral solution (syrup): Useful for children or those who have difficulty swallowing tablets[1].
  • Intravenous (IV) injection: Used in hospital settings or when oral administration is not possible[2].

The dosage of Lacosamide varies depending on the patient’s age, weight, and specific condition. For children, the dose is often calculated based on body weight, ranging from 2 mg/kg/day to 12 mg/kg/day[1]. For adults, doses typically range from 100 mg to 400 mg per day, divided into two doses[5].

It’s important to note that Lacosamide treatment is usually started at a lower dose and gradually increased over time to reach the most effective dose with minimal side effects. This process is called titration[1].

Effectiveness

Clinical trials have shown Lacosamide to be effective in reducing the frequency of seizures in both adults and children with partial-onset epilepsy. Some key findings include:

  • Reduction in seizure frequency: Many patients experience a significant decrease in the number of seizures they have[1].
  • Improved seizure control: Some patients achieve a 50% or greater reduction in seizure frequency[5].
  • Long-term effectiveness: Studies have shown that Lacosamide can maintain its effectiveness over extended periods, with some trials lasting up to 2 years[6].

Side Effects and Safety

Like all medications, Lacosamide can cause side effects. Common side effects may include:

  • Dizziness
  • Headache
  • Nausea
  • Double vision
  • Fatigue

Most side effects are mild to moderate and often improve as the body adjusts to the medication. However, it’s important to report any persistent or severe side effects to your healthcare provider[1][2].

In rare cases, more serious side effects can occur, including changes in heart rhythm or severe allergic reactions. If you experience any unusual symptoms, seek medical attention immediately[2].

Special Considerations

There are several important factors to consider when taking Lacosamide:

  • Pregnancy and breastfeeding: The safety of Lacosamide during pregnancy and breastfeeding is not fully established. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits with your doctor[1].
  • Cognitive effects: Some studies have investigated the potential cognitive and behavioral effects of Lacosamide. While generally well-tolerated, it’s important to report any changes in thinking, mood, or behavior to your healthcare provider[7].
  • Drug interactions: Lacosamide may interact with other medications. Always inform your doctor about all medications, supplements, and herbal products you are taking[8].
  • Sudden discontinuation: Do not stop taking Lacosamide suddenly without consulting your doctor, as this can increase the risk of seizures[5].

Remember, Lacosamide is a prescription medication that should only be taken under the guidance of a healthcare professional. Regular check-ups and open communication with your doctor are essential for ensuring the safe and effective use of this medication.

Aspect Details
Study Populations Adults and children with partial-onset seizures
Administration Routes Oral (tablets, syrup) and intravenous
Dosage Ranges Children: 2-12 mg/kg/day; Adults: 100-600 mg/day
Primary Outcomes Safety, tolerability, adverse events, seizure frequency reduction
Secondary Outcomes Pharmacokinetics, quality of life measures, cognitive effects
Study Designs Open-label, randomized, double-blind, placebo-controlled
Treatment Duration Varied from short-term (weeks) to long-term (years)

FAQ

  • What is lacosamide used to treat? Lacosamide is primarily used to treat partial-onset seizures in patients with epilepsy. It has been studied as an add-on therapy to other antiepileptic drugs as well as a potential monotherapy option.
  • How is lacosamide administered? Lacosamide can be administered orally as tablets or syrup, or intravenously as an infusion. The specific formulation and dosage depend on the patient's age, weight, and individual needs.
  • What are the common side effects of lacosamide? Common side effects observed in clinical trials include dizziness, headache, nausea, and fatigue. However, the full range of potential side effects is monitored closely in each study.
  • Has lacosamide been studied in children? Yes, several clinical trials have investigated the use of lacosamide in pediatric patients with epilepsy, evaluating its safety, tolerability, and efficacy in children of various ages.
  • What dosages of lacosamide have been studied? Clinical trials have examined a range of lacosamide dosages, typically from 2 mg/kg/day up to 12 mg/kg/day in children, and from 100 mg/day to 600 mg/day in adults, depending on the specific study design and patient population.

Ongoing Clinical Trials on Lacosamide

  • Study of anti-seizure drug combination in comatose patients with status epilepticus after cardiac arrest

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium The Netherlands

  • Study on Fast Sedation with Propofol and Midazolam vs. Anti-Seizure Drug Combination for Treating Refractory Status Epilepticus in Intensive Care Patients

    Recruiting

    3 1 1 1
    Investigated drugs:
    Denmark

  • Study on Lacosamide and Duloxetine for Patients with Chemotherapy-Induced Neuropathic Pain

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Long-Term Safety Study of Lacosamide for Children with Epilepsy

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Hungary Romania

Glossary

  • Adjunctive therapy: A treatment used in addition to the primary or initial treatment to improve its effectiveness.
  • Monotherapy: The use of a single drug to treat a particular condition.
  • Partial-onset seizures: Seizures that begin in one area of the brain, also known as focal seizures.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Efficacy: The ability of a drug to produce the desired therapeutic effect.
  • Tolerability: The degree to which side effects of a drug can be tolerated by a patient.
  • Treatment-emergent adverse event (TEAE): Any unfavorable medical occurrence that emerges or worsens during treatment with a drug.
  • Titration: The process of gradually adjusting the dose of a medication to find the optimal balance between effectiveness and side effects.
  • Maintenance period: The phase of treatment after initial titration where the drug dose remains stable for a set duration to assess long-term effects.
  • Defined Daily Dose (DDD): The assumed average maintenance dose per day for a drug used for its main indication in adults.

References

  1. https://clinicaltrials.gov/study/NCT01969851
  2. https://clinicaltrials.gov/study/NCT00655551
  3. https://clinicaltrials.gov/study/NCT00440518
  4. https://clinicaltrials.gov/study/NCT05626140
  5. https://clinicaltrials.gov/study/NCT00520741
  6. https://clinicaltrials.gov/study/NCT01964560
  7. https://clinicaltrials.gov/study/NCT01175954
  8. https://clinicaltrials.gov/study/NCT01450111